Medical Oncology Department, Centre Léon Bérard, Lyon, France.
Department of Pharmacy, Centre Léon Bérard, Lyon, France.
JCO Clin Cancer Inform. 2024 Oct;8:e2400205. doi: 10.1200/CCI-24-00205. Epub 2024 Oct 25.
Therapeutic compliance, or adherence, is critical in oncology because of the complexity and duration of cancer treatment regimens. Nonadherence can lead to suboptimal therapeutic outcomes, increased disease progression, higher mortality rates, and elevated health care costs. Traditional methods to enhance compliance, such as patient education and regular follow-ups, have shown limited success.
This review examines the potential of digital health technologies to improve adherence in oncology. Various studies and trials are analyzed to assess the effectiveness of these technologies in supporting patients with cancer.
mHealth applications have been shown to improve medication adherence through features like medication reminders and symptom tracking. Telemedicine facilitates continuous care and reduces the need for travel, significantly improving adherence and patient satisfaction. Patient-reported outcome measures enhance clinical decision making and personalized treatment plans by incorporating patient feedback. Electronic medical records and patient portals improve compliance by providing easy access to medical information and fostering better patient-provider communication. Connected pillboxes aid in consistent medication intake and reduce dispensing errors.
Digital health technologies offer significant benefits in oncology by enhancing patient engagement, improving adherence to treatment protocols, and enabling comprehensive cancer care management. However, challenges such as the digital divide, data privacy concerns, and the need for tailored interventions must be addressed. Future research should focus on evaluating the effectiveness of digital interventions and developing personalized digital health tools to maximize therapeutic compliance.
由于癌症治疗方案的复杂性和长期性，治疗依从性（或遵医行为）在肿瘤学中至关重要。不遵医嘱可能导致治疗效果不佳、疾病进展加速、死亡率上升和医疗保健成本增加。传统的提高依从性的方法，如患者教育和定期随访，已经显示出成效有限。
本文综述了数字医疗技术在改善肿瘤学依从性方面的潜力。分析了各种研究和试验，以评估这些技术在支持癌症患者方面的有效性。
移动医疗应用程序通过药物提醒和症状跟踪等功能，已被证明可以提高药物依从性。远程医疗促进了连续护理，并减少了旅行的需求，极大地提高了依从性和患者满意度。患者报告的结果测量通过纳入患者反馈，增强了临床决策和个性化治疗计划。电子病历和患者门户通过提供便捷的医疗信息访问和促进更好的医患沟通，提高了依从性。互联药盒有助于确保患者按时服药，减少配药错误。
数字医疗技术在肿瘤学领域具有显著优势，通过增强患者参与度、提高治疗方案的依从性以及实现全面的癌症护理管理，为患者带来了益处。然而，必须解决数字鸿沟、数据隐私问题以及需要量身定制干预措施等挑战。未来的研究应侧重于评估数字干预措施的有效性，并开发个性化的数字医疗工具，以最大限度地提高治疗依从性。
